When considering problems of premalignancy, it is essential to define exactly what is meant by this term. A distinction can be made between a precancerous condition and a precancerous lesion (WHO 1964) . The former is best regarded as a clinical state associated with a significantly increased risk of cancer, whereas a precancerous lesion is a histopathological abnormality in which cancer is more likely to occur than in its apparently normal counterpart. In many clinical conditions with an increased risk of cancer there is also an indentifiable precancerous lesion, but this is not invariably so.
With regard to the colorectum, there are five groups of patients among whom both clinical as well as histological markers for increased cancer risk can be identified. These are patients with colorectal adenomas; those who have had one cancer removed by partial removal of the large bowel; familial polyposis families; colorectal cancer families; and certain patients with chronic ulcerative colitis. The magnitude of the risk is very variable and attempts to measure this have immense importance for cancer prevention. The aim must be to identify markers for especially high cancer risk because of the administrative, economic and technical problems involved in screening large numbers of persons most of whom are not destined to get colorectal cancer. . The histological marker for increased risk which IS common to all these patients is epithelial dysplasia . ?r atypia, and the criteria used by pathologists in Its recognition are fundamentally no different from t?ose applied to premalignancy in the skin, cervix, Ĩer, urothelium and other epithelium-lined cavtties. The colorectal adenoma is a form of localized, polypoid dysplasia and is the precancerous lsi on common to all the groups of patients mentioned above, except those with ulcerative colitis. In this disease, dysplasia is nearly always diffuse and arises in a flat as often as a polypoid mucosa, but the histology is fundamentally the same. As in other organs, dysplasia in the colon can be graded as mild, moderate or severe with the latter being equated with carcinoma-in-situ, although this is not an expression favoured for the colon because of its emotive meaning for some (Morson 1978 (Morson 1978) , but which might more accurately be called the dysplasiacarcinoma sequence in order to conform with the life history of malignant disease as we see it in other epithelial organs.
• Colorectal polyps, as observed endoscopically and radiologically, are very common. It must be emphasized that only those identified by the histopathologist as belonging to the adenoma group of tumours have any malignant potential. This is still a large number of persons and further refinement of the magnitude of the cancer risk is required. In the present state of knowledge it would appear that risk of malignant change is closely related to size of adenoma, being negligible in tumours one centimetre or less in diameter but becoming greater with increasing size over this critical point. Most adenomas are small and experience suggests that only a small minority of them grow to sufficient size for the cancer risk to become significant. It follows that polyps over one centimetre in diameter which have been detected by endoscopic or radiological examination should always be removed. It has also been shown that the histological type of adenoma is important; villous and tubulovillous adenomas have greater potential for malignant change than tubular adenomas. When epithelial dysplasia is graded as severe the malignant potential is greatest. Severe dysplasia is mostly found in the larger adenomas and in those with a villous component in their histological structure (M uto et al. 1975) .
Unfortunately, many patients with colorectal adenomas have minor clinical symptoms or no symptoms at all. On the assumption, however, that all adenomas (and cancers) bleed, which is almost certainly correct, an improved method has been introduced for the detection of occult blood in the stools (Greegor 1972 , Winawer et al. 1976 ). The impregnated guaiac slide (haemoccult) test answers many of the criticisms of the older methods of testing for occult blood. Further study will be needed to evaluate the application of this test in the development of mass screening programmes, but it could be argued that a positive haemoccult test places a patient in an 'increased risk group' for colorectal adenoma or cancer and this should be followed at least by sigmoidoscopy and barium enema, if not by colonoscopy. The numbers of patients considered to be at risk by this method might be very large with a consequent strain on existing resources of money and expertise.
Preliminary data, however, suggest that a screening test based on the potential for polyps and cancers to bleed has considerable promise in the detection of the adenoma-carcinoma sequence at a curable stage.
One important reason why patients who have had a bowel resection for cancer should be advised to submit to indefinite follow up and periodic investigation is that they are at increased risk from a second primary cancer which is usually manifest many years after the original operation. In these patients the concept of the adenoma-carcinoma sequence is the basis upon which risk is evaluated. Thus, the risk is highest in those who had one adenoma or more as well as the cancer in the first operation specimen. The magnitude of the risk increases with time after about five years postoperatively and on average the second cancer is discovered about eleven years after the first (Heald & Lockhart-Mummery 1972) .
There is evidence that the greater the numbers of colorectal adenomas in a patient the greater the risk of cancer (Muto et al. 1975) . This arithmetical approach becomes of great significance in patients with more than one hundred adenomas because, by definition, they are then found to have the hereditary disease known as familial polyposis coli. The cancer risk in such patients is known to be almost inevitable. It happens that whereas it is not unusual to come across individuals with up to ten adenomas, it is rare to see them with more than this number unless they have familial polyposis, in which case they usually have many thousands of adenomas including those of microscopic dimensions (microadenomas).
In the past it has become customary to regard polyposis as a wholly separate disease on the assumption that the adenomas present in this condition differ from those found as isolated lesions. Apparent differences have been reported (Leuchtenberger et al. 1956 , Birbeck & Dukes 1963 , but these have failed to stand up to closer scrutiny, and the only differences between the adenomas of polyposis and nonpolyposis patients would appear to be the number of tumours and possibly the mode of inheritance. This being so, it would seem reasonable, therefore, to regard polyposis with its heavy concentration of adenomas as a fruitful field for the study of the adenomacarcinoma sequence.
In the investigation, treatment and follow up of polyposis families, the important objective is to get affected individuals treated before they develop cancer. Cancer prevention has limited scope in the propositus group, as two-thirds of these patients already have cancer when first seen. The incidence of malignancy among the siblings, however, is considerably less than that found in propositus family members and the reduction is even greater among the children of affected members. The records of the St Mark's Hospital Polyposis Register show a dramatic decrease in malignant disease among call-up family members as compared with the propositus group. When polyposis is diagnosed before cancer has occurred, the adenoma-carcinoma sequence can be broken by surgical removal of the adenomas. This may be effected by either total proctocolectomy or colectomy and ileorectal anastomosis. The former makes certain that no further adenomas are produced, but leaves the patient with the permanent handicap of an ileostomy; the latter demands halfyearly review for the destruction of any polyps in the rectum. Moertel et al. (1970) report that this procedure carries a heavy risk of subsequent malignancy in the rectum, which they estimate to be an accumulative 59% at 23 years after operation. This has not been confirmed by Schaupp & Volpe (1972) , who record only one case of subsequent rectal carcinoma although 30 patients had been followed up for ten years or more. Bussey (1975) has also reported a lower figure of 3.6% at 25 years. Cancer prevention can be said to have been highly effective in the cooperative polyposis family up to the present, and should be even more so in the future. Indeed, with a complete record of all polyposis families and their total cooperation, it should be possible to reduce the incidence of associated cancer of the colon and rectum to a negligible figure. The good results obtained in the St Mark's Hospital series (Bussey 1975) not only provide evidence that the destruction of adenomas is an effective method of cancer prevention, but also point the way to a possible reduction of the incidence of intestinal cancer in the general population.
There are valuable opportunities for cancer prevention among so-called colorectal cancer families (Lovett 1976) . Every patient with colorectal cancer should be questioned for evidence of a family history of adenomas or cancer of the colon or rectum. A positive history should lead to careful documentation of all relatives, particularly siblings and children of affected members, in the same way that construction of a family pedigree provides the essential information required for the care of a polyposis family. In the St Mark's Hospital cancer family register there are 70 families with two affected members, 18 with three and 10 with four. The age of onset of colorectal cancer in these patients is significantly younger than in the general population and they have an increased incidence of multiple tumours. These patients have not got polyposis, but there is evidence that the incidence of adenomas is increased compared with patients without a family history, giving further support to the concept of the adenoma-carcinoma sequence (Bussey et al. 1979) . Members of cancer families, particularly siblings, should be invited for investigation or at least warned never to neglect symptoms relating to the large bowel. Parents, one of whom has had a cancer or is at increased risk because of the family history, should be encouraged to have their children examined, but current information suggests that this is unnecessary until about the age of 20 years.
Most patients with ulcerative colitis never develop carcinoma of the large bowel. However, it is established that such tumours are more common in colitics than in the general population and tend to occur at an earlier age. Many published studies have confirmed that the cancer risk is largely confined to those with extensive colitis, a history of symptoms for more than ten years and histological evidence of severe dysplasia in colorectal biopsies. It is probable that carcinoma as a complication of colitis could largely be eliminated by advising proctocolectomy for all patients with extensive colitis, either early in the course of the disease for acute symptoms or after ten years in patients with mild disease (Bonnevie et at. 1974) . This policy would greatly increase the number of patients undergoing major surgery, most of whom are not destined to get colorectal cancer. These operations have a mortality and morbidity both in the short and the long term (Ritchie 1972) and excision of the rectum can lead to sexual dysfunction (Burnham et al. 1977) . The presence of a stoma can cause physical, psychological and social disability. An alternative policy reserves operation for a patient with ill-health due to colitis or when the large intestine shows evidence of neoplastic potential as judged by the presence of consistent and severe epithelial dysplasia in colorectal biopsies (Morson & Pang 1967) .
A prospective study has now shown that the cancer risk in colitis can be minimized by careful follow up of all patients with a long history of extensive disease and prophylactic proctocolectomy performed when evidence of severe dysplasia is established .This is a small and manageable population of patients, like polyposis and colorectal cancer families, among Whom a cancer prevention programme is a proven SUccess. .
The information made available in recent decades by cancer registries has been of enormous value in defining large populations, usually at a national level, who are at increased risk from different varieties of malignant disease. Has the time now arrived for the establishment of official precancer registers on a regional or national basis? This would certainly be practicable for polyposis coli families, colorectal cancer families and colitics at increased risk, and there is now incontrovertible evidence that this would lead to cancer prevention. But there is also the prospect that the registration 0141-0768/79/020085-03/$01.00/0 of patients with Isolated large bowel adenomas or even those with a positive stool haemoccult test might be beneficial and cost-effective. If cancer prevention is to be more than a political or professional slogan then it is time consideration was given to such proposals by our public health authorities. St Mark's Hospital, London EC1 
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